A novel t(2;17) in transformation of essential thrombocythemia to acute myelocytic leukemia

Vladimir Lj Lazarevic, Dragica Tomin, Gradimir M Jankovic, Darko Antic, Marija Dencic, Mirjana Gotic, Darinka Boskovic

Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskriftPeer review

Sammanfattning

A transformation of essential thrombocythemia to acute myelocytic leukemia (AML), myelodysplastic syndrome, or agnogenic myelocytic metaplasia is a relatively rare event. It occurs in 1%-4.5% of all patients with either treated or untreated essential thrombocythemia. Cytogenetic changes in the transformation to AML are common. We report the case of a patient treated for essential thrombocythemia with hydroxyurea for 49 months. He developed AML with a t(2;17), which to our knowledge has not been described in the literature.

Originalspråkengelska
Sidor (från-till)77-9
Antal sidor3
TidskriftCancer Genetics and Cytogenetics
Volym148
Nummer1
DOI
StatusPublished - 2004 jan. 1
Externt publiceradJa

Fingeravtryck

Utforska forskningsämnen för ”A novel t(2;17) in transformation of essential thrombocythemia to acute myelocytic leukemia”. Tillsammans bildar de ett unikt fingeravtryck.

Citera det här